In the last trading session, 4.43 million Indaptus Therapeutics Inc (NASDAQ:INDP) shares changed hands as the company’s beta touched 1.63. With the company’s per share price at $1.91 changed hands at $0.44 or 29.76% during last session, the market valuation stood at $19.46M. INDP’s last price was a discount, traded about -70.16% off its 52-week high of $3.25. The share price had its 52-week low at $1.03, which suggests the last value was 46.07% up since then. When we look at Indaptus Therapeutics Inc’s average trading volume, we note the 10-day average is 29430.0 shares, with the 3-month average coming to 17.34K.
Indaptus Therapeutics Inc (NASDAQ:INDP) trade information
Instantly INDP was in green as seen at the end of in last trading. With action 50.19%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 8.38%, with the 5-day performance at 50.19% in the green. However, in the 30-day time frame, Indaptus Therapeutics Inc (NASDAQ:INDP) is 49.02% up. Looking at the short shares, we see there were 34151.0 shares sold at short interest cover period of 1.54 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Indaptus Therapeutics Inc (INDP) estimates and forecasts
Data shows that the Indaptus Therapeutics Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -23.40% over the past 6 months, a 2.19% in annual growth rate that is considerably lower than the industry average of 17.50%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 56.03%. The 2024 estimates are for Indaptus Therapeutics Inc earnings to decrease by -3.55%.
INDP Dividends
Indaptus Therapeutics Inc is expected to release its next quarterly earnings report in November.
Indaptus Therapeutics Inc (NASDAQ:INDP)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 26.67% of Indaptus Therapeutics Inc shares while 5.88% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 8.02%. There are 5.88% institutions holding the Indaptus Therapeutics Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 3.0355% of the shares, roughly 0.26 million INDP shares worth $0.54 million.
INVESTMENT HOUSE LLC holds the second largest percentage of outstanding shares, with 1.2134% or 0.1 million shares worth $0.22 million as of 2024-06-30.
